Nizar Chahin, M.D.
- Associate Professor of Neurology, School of Medicine
Biography
Dr. Chahin is only accepting new patients with myositis.
Dr. Chahin, having trained in three fellowships at mayo clinic and having been on staff for many years at both university of North Carolina and Connecticut, has extensive expertise in diagnosing and treating patients with diverse neuromuscular disorders (disorders that affect muscle or nerves or the connection between muscle and nerves). His main interest is in diagnosing and treating patients with inflammatory myopathy, a disease that causes inflammation in the muscle.
In his spare time, Dr Chahin enjoys spending time with his family.
Education and training
-
Residency
- University of Missouri, Columbia, MO
-
Fellowship
- -Muscle disease fellowship, Mayo Clinic, Rochester, MN, 2003-2005
- -Peripheral nerve disease fellowship, Mayo clinic, Rochester, MN, 2005-2006
- -EMG fellowship, Mayo Clinic, Rochester, MN, 2006-2007
-
Certifications
- American Board of Psychiatry and Neurology
- Clinical neurophysiology
- Neuromuscular medicine
- Clinical neuromuscular pathology
Memberships and associations:
- American Academy of Neurology
Publications
Elsevier pure profilePublications
Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy
Arthritis Care and ResearchNeurosarcoidosis manifesting as focal sacral inflammatory radiculopathy
BMJ Case ReportsSafety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001)
The Lancet NeurologyCoexisting sporadic late onset nemaline myopathy and AL amyloid myopathy – incidental or related?
Neuromuscular DisordersUnusual cases of Anti-SRP necrotizing myopathy with predominant distal leg weakness and atrophy
Neuromuscular DisordersCIDP mimics
BMC NeurologySafety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET)
The Lancet NeurologySafety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT)
The Lancet NeurologyDiagnosis of paraproteinemic neuropathy
Journal of the neurological sciencesNusinersen in adult patients with spinal muscular atrophy
NeurologyRefractory CIDP
Journal of the neurological sciencesScreening for genetic mutations in patients with neuropathy without definite etiology is useful
Journal of NeurologyUnwarranted, long term, alglucosidase alfa enzyme replacement therapy in two non-Pompe disease patients
Clinical Neurology and NeurosurgeryBright tongue sign in patients with late-onset Pompe disease
Journal of NeurologySelective serotonin reuptake inhibitors ameliorate MEGF10 myopathy
Human molecular geneticsDiagnostic utility of exome sequencing in the evaluation of neuromuscular disorders
Neurology: GeneticsClinical Reasoning
NeurologyClinical Sequencing Exploratory Research Consortium
American Journal of Human GeneticsDermatomyositis as a presentation of neuromyelitis optica spectrum disorder
Journal of NeuroimmunologyLate-onset Becker muscular dystrophy
Muscle and NerveToxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease
Neurology: Neuroimmunology and NeuroInflammationCharacteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy
Neuromuscular DisordersPearls and Oy-sters
Neurology